RE:RE:Good time to SELL!Agreed.
She was built specifically for this role by working at Goodman's side all these years.
She does the day-to-day and makes it more efficient while drugs are added.
Her financial ability will we key in emerging markets.
Meanwhile, Goodman worries about the strategic developments.
Together ... they make it happen !
Early days are a bich but that is totally expected with this one.
Just a reminder, Goodman started his first company in 1996 and had a foot in emerging markets by 2010. They had minority ownership of Pharmaplan 14 years in. We have 100% ownship in North America (x-USA) in 7+ years.
That's one way of looking at - and - a fairly important one for certain key investors.
Not trying to get you to buy shares - sharing how I've been looking at this investment all along.
---------------
Paladin makes first step into emerging markets with 35% ownership of Pharmaplan:
https://www.biospace.com/article/releases/paladin-labs-inc-makes-first-step-into-emerging-markets-through-strategic-investment-in-b-pharmaplan-b-/ 2 years later ... swapped it out in a deal for 45% ownership in Litha/Parmaplan (also in South Africa):
https://www.theglobeandmail.com/globe-investor/paladin-labs-to-buy-45-stake-in-south-africas-litha/article547654/ Snowballgrowth wrote: indoubtgetout wrote: New CEO is the same as the old CEO - pathetic!! Good time to GTFO!!
I think she will be a very good CEO. Well desserve.